 WOODCLIFF LAKE, N.J.--BUSINESS WIRE--Eagle Pharmaceuticals, Inc. Nasdaq: EGRX Eagle or the Company today announced that, on January 29, 2021, the United States District Court for the District of Delaware the Court postponed the February 1, 2021 vasopressin trial between Eagle and Endo Par Innovation Company, LLC, et al. The Court expects to hold a call with the parties today to discuss a new trial date. Scott Tarriff, Chief Executive Officer of Eagle Pharmaceuticals, stated, Par 